Hypertension, antihypertensive drugs, and age at onset of Huntington’s disease
Abstract Background Associations between blood pressure (BP) with age at onset of Huntington’s disease (HD) have reported inconsistent findings. We used Mendelian randomization (MR) to assess effects of BP and lowering systolic BP (SBP) via the genes encoding targets of antihypertensive drugs on age...
Main Authors: | Yahui Zhu, Mao Li, Jiongming Bai, Haoran Wang, Xusheng Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13023-023-02734-1 |
Similar Items
-
Genetically predicted hypertension, antihypertensive drugs, and risk of erectile dysfunction: a Mendelian randomization study
by: Cong Zhao, et al.
Published: (2023-06-01) -
Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations
by: Bohan Fan, et al.
Published: (2024-01-01) -
Association between Genetically Proxied Inhibition of HMG-CoA Reductase and Age at Onset of Huntington’s Disease
by: Yahui Zhu, et al.
Published: (2022-11-01) -
ANTIHYPERTENSIVE DRUG THERAPY FOR HYPERTENSIVE DISORDERS IN PREGNANCY
by: Slobodan Jankovic, et al.
Published: (2008-10-01) -
What drugs do hypertension patients take in clinical practice? Structure of antihypertensive drugs in a large siberian region
by: Y. I. Grinshtein, et al.
Published: (2016-12-01)